Earnings Call · Q4 FY2022·2023-03-30

Q4 22EPS -5.26%·Rev n/aQ3 22EPS +26.09%·Rev n/aQ2 22EPS +9.52%·Rev n/aQ1 22EPS +18.18%·Rev n/a⚠ consensus missing

CorMedix Inc. CRMD

Dan Ferry — Investor Relations or IR Representative

Joe Todisco — Chief Executive Officer

Phoebe Mounts — Executive Vice President and General Counsel

Matt David — Executive Vice President and Chief Financial Officer

+13.1%1d on move date+12.5% vs SPY3d+18.3%5d+12.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRMD calls or request research access.

More CRMD calls Browse calls Request research access